Invention Grant
- Patent Title: Use of cell membrane-bound signaling factors
-
Application No.: US16763959Application Date: 2018-11-16
-
Publication No.: US11666522B2Publication Date: 2023-06-06
- Inventor: Gabriel Nistor
- Applicant: AiVita Biomedical, Inc.
- Applicant Address: US CA Irvine
- Assignee: AIVITA BIOMEDICAL, INC.
- Current Assignee: AIVITA BIOMEDICAL, INC.
- Current Assignee Address: US CA Irvine
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/061550 2018.11.16
- International Announcement: WO2019/099850A 2019.05.23
- Date entered country: 2020-05-13
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K47/40 ; C07K14/47 ; C12N5/0735 ; C12N5/074 ; A61K8/73 ; A61K47/61 ; A61K47/54 ; A61K47/69 ; A61K8/64 ; A61K9/00 ; A61K9/08 ; A61K38/18 ; A61K47/26 ; A61Q7/00 ; C12N5/00
Abstract:
Disclosed herein are compositions comprising complexes of cyclodextrins and lipid-modified stem cell proteins. Also disclosed are topical compositions the complexes. Methods of using the compositions for the therapeutic purposes are also disclosed as well as methods of producing the compositions.
Public/Granted literature
- US20210379200A1 USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS Public/Granted day:2021-12-09
Information query
IPC分类:
